Filing Flows

Filing Flows › Teradyne (TER) › Q4 2025

Teradyne (TER) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Feb 19, 2026

Teradyne (TER) reported revenue of $1.1B for the fourth quarter 2025 (Q4 2025), +44% from a year earlier and +41% from the quarter before. Operating margin was 27.1%, net earnings $257M (23.7% of revenue).

Revenue$1.1B
Year over year+44%
Quarter over quarter+41%
Operating margin27.1%
Net earnings$257M

Teradyne, Q4 2025: revenue $1.1B (+44% year over year), operating margin 27.1%, net earnings $257M, operating cash flow $282M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$1.1B+41%+44%
Gross profit$620M+38%+39%
Operating profit$293M+102%+91%
Net earnings$257M+115%+76%
Operating cash flow$282M+474%-0.3%
Free cash flow$219M93×-3%

What changed

Revenue was $1.1B in Q4 2025, up 44% year over year and up 41% from the previous quarter. Product was the largest line at 87% of revenue.

Gross margin was 57.2%, down 2.2 points from a year earlier. Operating profit was $0.29B, a 27.1% margin (up 6.7 points year over year). Of the extra revenue versus a year earlier, 42% reached operating profit, above the 20% margin then. Operating expenses grew 11% against revenue growth of 44%. The fastest-growing cost line was Other operating costs (+94%). Net earnings were $0.26B, up 76% year over year. The effective tax rate was 10.2%.

Operating cash flow was $0.28B (roughly flat year over year), 109% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.03B. Capital expenditures of $0.06B left free cash flow of $0.22B.

Questions

What was Teradyne's revenue in the fourth quarter 2025?

Teradyne (TER) reported revenue of $1.1B for the fourth quarter 2025 (Q4 2025), +44% from a year earlier and +41% from the quarter before.

Was Teradyne profitable in the fourth quarter 2025?

Operating profit was $293M (27.1% of revenue) and net earnings $257M.

Open the interactive Sankey →

Source: Teradyne 10-K on SEC EDGAR.